Eli Lilly is a major pharmaceutical corporation which develops, manufactures and markets pharmaceutical products. The company has major R&D facilities in seven countries and manufacturing facilities in 13 countries.
Eli Lilly will focus on its ‘innovation-driven’ strategy and invest in R&D with the goal of delivering a steady flow of innovative products. The company will also build the capabilities to manufacture these products and market them effectively around the world, and augment its own capabilities and resources through partnerships.
Eli Lilly is readying a generation of molecules for the market and restocking its early-stage pipeline. Its strength in developing both small-molecule and large-molecule ‘biotech’ medicines is said to distinguish Eli Lilly from most other major pharmaceutical companies.
Download the The ICIS Top 100 Chemical Companies listing here